NL-OMON47455
Completed
Not Applicable
Quantitative MR Imaging of skeletal muscle in Duchenne and Becker muscular dystrophy - Quantitative MRI in DMD and BMD
Radiologie0 sites74 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Duchenne muscular dystrophy
- Sponsor
- Radiologie
- Enrollment
- 74
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Trial is onging in other countries
Investigators
Eligibility Criteria
Inclusion Criteria
- •DMD and BMD patients of 5 years and older with typical muscle weakness and a known genetic mutation in the dystrophin gene.
- •Healthy age\-matched males of 5 years or older form the control group.
Exclusion Criteria
- •General exclusion criteria are:
- •\- Claustrophobia
- •\- Pacemakers and defibrillators
- •\- Nerve stimulators
- •\- Intracranial clips
- •\- Intraorbital or intraocular metallic fragments
- •\- Cochlear implants
- •\- Ferromagnetic implants (e.g. thoracic implant for scoliosis)
- •\- Inability to lie supine during less than 60 minutes;Exclusion criteria for healthy controls
- •\- any muscle disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
on-invasive assessment of skeletal muscle involvement in Duchenne muscular dystrophyDuchenne Muscular Dystrophy10028302NL-OMON39843eids Universitair Medisch Centrum38
Completed
Not Applicable
Magnetic Resonance Direct Thrombus Imaging for Suspected Thrombosis of Upper Extremity Diagnostic Evaluation (Selene Study)arm vein thrombosisupper extremity thrombosis10014523NL-OMON50636eids Universitair Medisch Centrum46
Completed
Not Applicable
Quantitative MRI of extra-ocular muscles in myasthenia gravisNL-OMON48436eids Universitair Medisch Centrum89
Completed
Not Applicable
ow-field MRI visualisation of gravity-dependent endograft migration in patients with suspected endoleaks after EVAR (endovascular aneurysm repair)Aorta dilation10002363NL-OMON48077niversiteit Twente10
Completed
Not Applicable
An Abdominal Imaging, Substrate Analysis and Laboratory Sample Collection sub-study for Participants Who Have enrolled in LAL-2-NH01Lipid storage diseaseWolman Disease10027424NL-OMON37869Synageva Biopharma Corp2